Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

avkare - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

par pharmaceutical, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bryant ranch prepack - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

state of florida doh central pharmacy - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

aurobindo pharma limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

par pharmaceutical inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.